Diferencia entre revisiones de «Peritonsillar cellulitis»

Sin resumen de edición
Línea 4: Línea 4:


==Clinical Features==
==Clinical Features==
*[[Sore throat]], odynophagia
*+/- [[fever]]
*+/- exudates, lymphadenopathy
==Differential Diagnosis==
{{Sore throat DDX}}
==Evaluation==
*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection  
*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection  
*Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration  
*Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration  
Línea 11: Línea 20:
* Do not recommend CT to differentiate PTA from cellulitis  
* Do not recommend CT to differentiate PTA from cellulitis  
**Recommend CT with IV contrast to identify deep space neck infection  
**Recommend CT with IV contrast to identify deep space neck infection  
*Clinical features may not always distinguish PTA from cellulitis
**24-hour trial of antimicrobial therapy may be helpful
***Response is defined by improvement of sore throat, fever, trismus or alleviation of tonsillar inflammation
==Differential Diagnosis==
{{Sore throat DDX}}
==Evaluation==


==Management==
==Management==
*Antibiotic therapy
*Antibiotic therapy
**Oral  
**Oral  
***Amoxicillin-clavulanate (45mg/kg per dose [max 875mg single dose]) x 12 hours in children; 875 mg x 12 hours in adults
***[[Amoxicillin-clavulanate]] (45mg/kg per dose [max 875mg single dose]) x 12 hours in children; 875 mg x 12 hours in adults
***Clindamycin (10mg/kg [max 600mg single dose]) x8 hours in children; 300-450mg x 6 hours in adults  
***[[Clindamycin]] (10mg/kg [max 600mg single dose]) x8 hours in children; 300-450mg x 6 hours in adults  
**Parenteral  
**Parenteral  
***Ampicillin-sulbactam (no MRSA coverage) IV (50mg/kg per dose [max 3g single dose]) x 6 hours children; 3g x6 hours adults
***[[Ampicillin-sulbactam]] (no MRSA coverage) IV (50mg/kg per dose [max 3g single dose]) x 6 hours children; 3g x6 hours adults
***Clindamycin IV (13mg/kg per dose [max 900mg single dose]) x8 hours children; 600mg x6-8 hours adults  
***[[Clindamycin]] IV (13mg/kg per dose [max 900mg single dose]) x8 hours children; 600mg x6-8 hours adults  
***If moderate to severe disease (toxic, temp>39C, drooling, respiratory distress) add IV vancomycin or linezolid assed to ampicillin-sulbactam or clindamycin
***If moderate to severe disease (toxic, temp>39C, drooling, respiratory distress) add IV [[vancomycin]] or [[linezolid]] to ampicillin-sulbactam or clindamycin


==Disposition==
==Disposition==
 
*Usually discharge


==See Also==
==See Also==
 
*[[PTA]]
*[[Pharyngitis]]


==External Links==
==External Links==

Revisión del 21:32 27 ene 2019

Background

  • Peritonsillar cellulitis- inflammatory reaction between palatine tonsil and pharyngeal muscle with no discrete collection of pus.
  • Peritonsillar abscess - collection of pus located between palatine tonsil and pharyngeal muscle.

Clinical Features


Differential Diagnosis

Acute Sore Throat

Bacterial infections

Viral infections

Noninfectious

Other

Evaluation

  • Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection
  • Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration
  • Submandibular ultrasound may be superior to intraoral ultrasound when limited by trismus or pain.
  • PTA will have echo-free cavity with irregular border
  • Peritonsillar cellulitis appears as homogenous area with no fluid collection
  • Do not recommend CT to differentiate PTA from cellulitis
    • Recommend CT with IV contrast to identify deep space neck infection

Management

  • Antibiotic therapy
    • Oral
      • Amoxicillin-clavulanate (45mg/kg per dose [max 875mg single dose]) x 12 hours in children; 875 mg x 12 hours in adults
      • Clindamycin (10mg/kg [max 600mg single dose]) x8 hours in children; 300-450mg x 6 hours in adults
    • Parenteral
      • Ampicillin-sulbactam (no MRSA coverage) IV (50mg/kg per dose [max 3g single dose]) x 6 hours children; 3g x6 hours adults
      • Clindamycin IV (13mg/kg per dose [max 900mg single dose]) x8 hours children; 600mg x6-8 hours adults
      • If moderate to severe disease (toxic, temp>39C, drooling, respiratory distress) add IV vancomycin or linezolid to ampicillin-sulbactam or clindamycin

Disposition

  • Usually discharge

See Also

External Links

References

  1. Melio, Frantz, and Laurel Berge. “Upper Respiratory Tract Infection.” In Rosen’s Emergency Medicine., 8th ed. Vol. 1, n.d.